Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
19,218 Lung Cancer
clinical trials

Solid and Hematological Malignancies Clinical Trial
Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination
Status: Enrolling, Phase
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Solid and Hematological Malignancies Clinical Trial
Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination
Status: Enrolling, Phase
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Solid and Hematological Malignancies Clinical Trial
Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination
Status: Enrolling, Phase
Updated: 12/31/1969
Stanford Cancer Institute, Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Oncology Clinical Trial
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins
mi
from
Lutherville, MD
Click here to add this to my saved trials
Oncology Clinical Trial
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
UPMC Cancer Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Oncology Clinical Trial
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Rochester, MN
Click here to add this to my saved trials
Oncology Clinical Trial
An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Arizona Cancer Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy
Status: Enrolling
Updated: 2/6/2018
Stanford University School of Medicine
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
Status: Enrolling, Phase II
Updated: 4/11/2018
University of Maryland Greenebaum Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
Status: Enrolling, Phase II
Updated: 4/11/2018
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects
Status: Enrolling, Phase I
Updated: 12/31/1969
Mary Crowley Cancer Research Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Wisconsin School of Medicine and Public Health
mi
from
Madison, WI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Maryland Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Inova Fairfax Hospital
mi
from
Fairfax, VA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Community Heart and Vascular Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
St. Vincent Medical Group
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Saint Luke's Hospital, Kansas City
mi
from
Kansas City, MO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
VA Long Beach Healthcare System
mi
from
Long Beach, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Kentuckiana Pulmonary Associates
mi
from
Louisville, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Aurora St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Yale-New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Tulane University
mi
from
New Orleans, LA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
NYU Langone Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
The University of Oklahoma Health Sciences Center (OUHSC)
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of California, Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Santa Barbara Cottage Hospital
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
South Miami Heart Specialists
mi
from
South Miami, FL
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Maine Medical Center
mi
from
South Portland, ME
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Florida Cancer Specialists
mi
from
Sarasota, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of LY3214996 Administered Alone or in Combination With Other Agents in Participants With Advanced/Metastatic Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Georgetown University Medical Center
mi
from
Washington DC,
Click here to add this to my saved trials
Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer With MET Exon 14 (METex14) Skipping Alterations or MET Amplification Clinical Trial
Tepotinib Phase II in Non-small Cell Lung Cancer (NSCLC) Harboring MET Alterations
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer With MET Exon 14 (METex14) Skipping Alterations or MET Amplification Clinical Trial
Tepotinib Phase II in Non-small Cell Lung Cancer (NSCLC) Harboring MET Alterations
Status: Enrolling, Phase II
Updated: 12/31/1969
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University Hospitals of Cleveland Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Rocky Mountain Cancer Centers - Denver Midtown
mi
from
Denver, CO
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Minnesota, Masonic Cancer Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Carcinoma, Non-Small-Cell Lung Clinical Trial
Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Texas Oncology-Tyler
mi
from
Tyler, TX
Click here to add this to my saved trials
Lung Neoplasm Clinical Trial
Veterans Affairs Lung Cancer Or Stereotactic Radiotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Hunter Holmes McGuire VA Medical Center, Richmond, VA
mi
from
Richmond, VA
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Evaluation of the Archimedes™ System for Transparenchymal Nodule Access 2
Status: Enrolling
Updated: 12/31/1969
Cancer Treatment Centers of America at Southwestern Regional Medical Center
mi
from
Tulsa, OK
Click here to add this to my saved trials
Squamous Non-small Cell Lung Cancer Clinical Trial
Sym004 in Combination With Nivolumab Versus Nivolumab Monotherapy in EGFR-amplified Squamous Non-Small Cell Lung Cancer
Status: Enrolling, Phase I, II
Updated: 12/13/2016
University of North Carolina- Lineberger Cancer Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling, Phase IV
Updated: 12/31/1969
Lehigh Valley Health Network
mi
from
Allentown, PA
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling, Phase IV
Updated: 12/31/1969
Local Institution
mi
from
Berkeley, CA
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling, Phase IV
Updated: 12/31/1969
Providence Regional Cancer Partnership
mi
from
Everett, WA
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling, Phase IV
Updated: 12/31/1969
St. Mary's Hospital Regional Cancer Center
mi
from
Grand Junction, CO
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling, Phase IV
Updated: 12/31/1969
Comprehensive Cancer Centers of Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling, Phase IV
Updated: 12/31/1969
Local Institution
mi
from
Macon, GA
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling, Phase IV
Updated: 12/31/1969
Local Institution
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling, Phase IV
Updated: 12/31/1969
Coastal Integrative Cancer Care
mi
from
San Luis Obispo, CA
Click here to add this to my saved trials
Lung Cancer Clinical Trial
An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers
Status: Enrolling, Phase IV
Updated: 12/31/1969
Guthrie Medical Group, PC
mi
from
Sayre, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Trial of Adcetris in CD30+ Malignant Mesothelioma
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)
Status: Enrolling, Phase II
Updated: 12/31/1969
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)
Status: Enrolling, Phase II
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)
Status: Enrolling, Phase II
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)
Status: Enrolling, Phase II
Updated: 12/31/1969
Yale Cancer Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase III
Updated: 12/31/1969
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase III
Updated: 12/31/1969
Indian River Med. Ctr.
mi
from
Vero Beach, FL
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Oncology, P.A.
mi
from
Bedford, TX
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase III
Updated: 12/31/1969
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase III
Updated: 12/31/1969
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase III
Updated: 12/31/1969
Local Institution
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase III
Updated: 12/31/1969
Comprehensive Cancer Centers of Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase III
Updated: 12/31/1969
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase III
Updated: 12/31/1969
Local Institution
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase III
Updated: 12/31/1969
Local Institution
mi
from
Sacramento, CA
Click here to add this to my saved trials
Non Small Cell Lung Cancer Clinical Trial
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Cancer Center - Sherman
mi
from
Sherman, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Emory University Hospital-Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Maryland Greenebaum Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Wayne State University/Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Vanderbilt University/Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Smilow Cancer Center at Yale New Haven Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
TR(ACE) Assay Clinical Specimen Study
Status: Enrolling
Updated: 1/16/2018
Albert Einstein Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
TR(ACE) Assay Clinical Specimen Study
Status: Enrolling
Updated: 1/16/2018
Tyler Hematology Oncology PA
mi
from
Tyler, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Los Angeles County-USC Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases
Status: Enrolling, Phase II
Updated: 12/31/1969
Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Lung Cancer Clinical Trial
Clinician-Patient Communication in Lung Cancer Care
Status: Enrolling, Phase
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials